PRELUDE CAPITAL MANAGEMENT, LLC - CLARUS THERAPEUTICS HLDNGS I ownership

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 21 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q3 2021$9,00011,7250.00%
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q4 2021
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 91$00.00%
NOMURA HOLDINGS INC 85,000$00.00%
Context Capital Management, LLC 62,175$00.00%
MIZUHO SECURITIES USA LLC 100,000$1,0000.00%
Caption Management, LLC 140,821$00.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders